Stocks › COGT
Cogent Biosciences, Inc. (COGT) stock analysis
SKIP 2% confidence · analysed Nov 3, 2026
On Nov 3, 2026, our model rated Cogent Biosciences, Inc. (COGT) SKIP with 2% confidence at a price of $31.06. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 66, showing healthy upward momentum without being stretched.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is about normal (0.8x the 20-day average).
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $43.39 and the swing low is $30.87; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The company reports a profit margin of 0.0%.
In its latest quarter it earned $-0.52 per share, which beat the $-0.56 analysts expected.
Wall Street's average rating is 1.3 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $55.82.
The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.02 (SKIP). Technicals: RSI 66.26, MACD bullish, price below SMA50. Fundamentals: margin 0.0%. Financial results: last EPS surprise +7.1%, next earnings 2026-11-05. Smart Money Concepts: ranging / no clear structure, price retesting a bullish order block, price retesting a bearish order block. FinGPT news read: positive. Reference price $31.06; no trade levels (SKIP).
Past ratings for COGT
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Nov 3, 2026 | SKIP | 2% | $31.06 | — |
"Move since" compares each call's price with the latest analysed price.
Frequently asked questions
Is COGT a buy right now?
As of Nov 3, 2026, our automated model rates Cogent Biosciences, Inc. (COGT) SKIP with 2% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Cogent Biosciences, Inc. report earnings next?
The next earnings report is expected around Nov 5, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.